Neuromodulation

Our focus

Electronic implantable technologies and minimally invasive therapies that help patients manage debilitating chronic pain and neurological conditions such as movement disorders.

Carmela's story

At Boston Scientific, we’re dedicated to working closely with physicians and their patients to develop meaningful, industry-leading solutions that can improve the quality of life for millions worldwide. Our personalized pain solutions are designed to offer the broadest selection of evidence-based treatment options that address multiple pain targets and change patients' lives.

Delivering meaningful innovation

Advancing deep brain stimulation.

Because Parkinson’s disease is a progressive, neurodegenerative disorder, it’s critical to provide therapy that is designed to adapt with the patient’s evolving needs. The Vercise Genus™ Deep Brain Stimulation (DBS) System offers a broad rechargeable and non-rechargeable battery portfolio with MRI conditionality.¹ The system is designed to treat the symptoms of Parkinson’s Disease and essential tremor by delivering superior precision and targeted therapy. With our proprietary Multiple Independent Current Control (MICC) and the Vercise Cartesia™ Directional Leads, physicians can offer unmatched precision, flexibility and control. These unique therapy options combined with advanced image guided programming features are designed to make it easier than ever to manage patients' symptoms and adapt for continued relief as the disease progresses.

Individualized chronic pain care.

Each patient experiences pain differently, and pain can change over time. As a result, there is a need for technologies with multiple options that adapt with the changing needs of the patient. Our robust portfolio of therapies helps physicians deliver individualized care across a wide spectrum of chronic pain issues.

Personalizing pain therapy.

Our WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems are designed to provide personalized, long-lasting pain relief. The portfolio of SCS devices is full-body MRI conditional², offering proprietary Fast-Acting Sub-perception Therapy (FAST™) engineered to provide profound paresthesia-free pain relief to patients in minutes, and our next-generation FAST AutoDose provides a proactive bolus multiple times a day. With the ability to provide multiple therapies in one device, patients and their physicians have safe and effective options to find the therapy that works best for them.³

A new way to treat pain.

The Intracept^TM Procedure* is a minimally invasive, outpatient procedure for patients with vertebrogenic pain. As the only U.S. Food and Drug Administration-cleared system designed to relieve vertebrogenic pain, the Intracept Procedure targets a specific nerve within the vertebra called the basivertebral nerve and has been shown to improve function and relieve pain long-term. The procedure is implant-free, preserving future treatment options for other spine conditions.

Setting the standard.

The Vertiflex^TM Procedure † is a clinically proven, minimally invasive solution designed to deliver long-term relief for the pain associated with moderate lumbar spinal stenosis (LSS). In a clinical study, many patients reduced the use of opioids after the Vertiflex Procedure.^4,5

Leading radiofrequency ablation.

We offer radiofrequency ablation (RFA) systems used by physicians to treat patients with chronic pain. RFA is a versatile outpatient procedure that is often used prior to SCS in the treatment continuum for chronic pain and has more than 50-year track record of providing relief for patients.

85 percent drop in opioid use (among Vertiflex procedure study completers).⁴,⁵

150,000 Parkinson's disease patients have undergone DBS and regained control and quality of life.⁶

Patients with tremor experienced an average of 70% reduction of symptoms, depending on type and location.⁷

Conditions we treat

Chronic Pain
Lumbar Spinal Stenosis
Parkinson’s Disease
Essential Tremor

30%

of people worldwide have chronic pain.⁹

People with chronic pain are three times more likely to develop symptoms of anxiety.¹⁰

8.5M

individuals live with Parkinson's disease worldwide.¹¹

10M

people with severe joint pain in the U.S.¹²

5.3M

people live with vertebrogenic pain in the U.S.¹³

Solutions we offer

Rechargeable and Non-rechargeable Spinal Cord Stimulator (SCS) Systems
Basivertebral Nerve Ablation
Indirect Decompression Systems
Radiofrequency Ablation Systems
Rechargeable and Non-rechargeable Deep Brain Stimulation (DBS) Systems

Product spotlights

WaveWriter Alpha ™ Spinal Cord Stimulator Systems

WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems

The WaveWriter Alpha SCS Systems are a comprehensive portfolio of full-body MRI conditional devices.² Boston Scientific SCS Systems can deliver multiple therapies simultaneously and have been clinically proven to provide greater relief from chronic pain.³

Learn more about the WaveWriter Alpha SCS System

Intracept™ Procedure

The Intracept Procedure is a minimally invasive, outpatient procedure for patients with vertebrogenic pain. The therapy uses targeted radiofrequency energy to stop the basivertebral nerve from transmitting pain signals to the brain and is designed to improve function and provide long-term relief.

Learn more about the Intracept Procedure

mySCS™ App

Boston Scientific can help maximize a patients’ chances for a successful SCS trial with the mySCS™ App. This mobile app is designed to provide simple progress tracking during a Boston Scientific SCS trial, personalized goal setting, real-time support, and a summary report that patients can share with their physicians.

Learn more about the mySCS App

Cognita™ Care

Cognita Care provides personalized support services and innovative tools to help Boston Scientific pain patients find and maintain effective, long-term relief.

Learn more about the Cognita Care

The Vertiflex™ Procedure†

The Vertiflex procedure is a safe, minimally invasive treatment that has been clinically proven to provide effective, long-term relief from pain associated with moderate lumbar spinal stenosis (LSS).

†Superion™ Indirect Decompression System

Learn more about the Vertiflex Procedure

The Vercise Genus™ Deep Brain Stimulation (DBS) System

The Vercise Genus™ Deep Brain Stimulation (DBS) System is designed to make it easier than ever to manage patients' symptoms and adapt for continued relief as the disease progresses.

Learn more about the Vercise Genus DBS System

Sources

Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.

The Vercise Genus™ DBS System provides MRI access to full-body 1.5T scans when used under certain conditions as defined in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems.
The WaveWriter Alpha™ and WaveWriter Alpha™ Prime Spinal Cord Stimulator Systems provide safe access to full-body 1.5T MRI scans when used with specific components and exposed to the MRI environment under the defined conditions in the ImageReady™ MRI Full Body Guidelines for WaveWriter Alpha™ and WaveWriter Alpha™ Prime Spinal Cord Stimulator Systems
Wallace MS, North JM, Phillips GM, et al. Combination therapy with simultaneous delivery of spinal cord stimulation modalities: COMBO randomized controlled trial. Pain Manag. 2023;13(3):171-184.
Nunley, et al. Journal of Pain Research. 2018:11 2943–2948.
Decrease in the proportion of patients using opioids compared to baseline at five year interval.
International Neuromodulation Society. https://www.neuromodulation.com/deep-brain-stimulation.
Farris SM, Giroux, ML. (2013). DBS: A Patient Guide to Deep Brain Stimulation. 1st ed. CreateSpace Independent Publishing Platform; 2013.
Cohen, P., Steven, Hooten, M., William, Vase, Lene (2021). Chronic pain: an update on burden, best practices, and new advances. Lancet Journal. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00393-7/fulltext
Harvard Health Publishing, Depression and Pain, March 21, 2017; https://www.health.harvard.edu/mind-and-mood/depression-and-pain
https://statics.teams.cdn.office.net/evergreen-assets/safelinks/1/atp-safelinks.html CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. All trademarks are the property of their respective owners
World Health Organization. (2023, August 9). Parkinson disease. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/parkinson-disease
CDC Journal Morbidity and Mortality Weekly Report 2014. https://www.cdc.gov/mmwr/index2014.html
Hoy D, March L, Brooks P, et al. The global burden of low back pain; estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases 2014;73:968-974. https://ard.bmj.com/content/73/6/968

*Intracept Intraosseous Nerve Ablation System